CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
0.38
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.4
Open* 0.42
1-Year Change* -75.44%
Day's Range* 0.4 - 0.42
52 wk Range 0.21-2.35
Average Volume (10 days) 91.40K
Average Volume (3 months) 3.30M
Market Cap 22.36M
P/E Ratio -100.00K
Shares Outstanding 58.83M
Revenue 23.98M
EPS -0.35
Dividend (Yield %) N/A
Beta 1.13
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 11, 2024 0.38 0.00 0.00% 0.38 0.38 0.38
Apr 10, 2024 0.39 -0.03 -7.14% 0.42 0.42 0.39
Apr 9, 2024 0.44 -0.01 -2.22% 0.45 0.45 0.44
Apr 8, 2024 0.48 0.05 11.63% 0.43 0.48 0.43
Apr 5, 2024 0.44 -0.02 -4.35% 0.46 0.46 0.43
Apr 4, 2024 0.46 0.00 0.00% 0.46 0.46 0.46
Apr 3, 2024 0.45 -0.01 -2.17% 0.46 0.47 0.45
Apr 2, 2024 0.47 0.01 2.17% 0.46 0.47 0.46
Apr 1, 2024 0.46 0.01 2.22% 0.45 0.46 0.45
Mar 28, 2024 0.46 0.01 2.22% 0.45 0.46 0.44
Mar 27, 2024 0.44 0.01 2.33% 0.43 0.45 0.43
Mar 26, 2024 0.44 -0.01 -2.22% 0.45 0.45 0.44
Mar 25, 2024 0.47 -0.03 -6.00% 0.50 0.50 0.46
Mar 22, 2024 0.50 -0.03 -5.66% 0.53 0.53 0.50
Mar 21, 2024 0.53 -0.01 -1.85% 0.54 0.55 0.52
Mar 20, 2024 0.56 -0.02 -3.45% 0.58 0.59 0.56
Mar 19, 2024 0.58 0.01 1.75% 0.57 0.58 0.55
Mar 18, 2024 0.59 0.07 13.46% 0.52 0.61 0.51
Mar 15, 2024 0.49 0.03 6.52% 0.46 0.49 0.45
Mar 14, 2024 0.45 -0.01 -2.17% 0.46 0.46 0.45

Streamline Events

Time (UTC) Country Event
Thursday, April 25, 2024

Time (UTC)

20:35

Country

US

Event

Q4 2023 Streamline Health Solutions Inc Earnings Release
Q4 2023 Streamline Health Solutions Inc Earnings Release

Forecast

-

Previous

-
Friday, June 14, 2024

Time (UTC)

14:00

Country

US

Event

Streamline Health Solutions Inc Annual Shareholders Meeting
Streamline Health Solutions Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 24.889 17.379 11.346 11.853 22.365
Revenue 24.889 17.379 11.346 11.853 22.365
Cost of Revenue, Total 13.395 8.577 5.689 5.351 8.137
Gross Profit 11.494 8.802 5.657 6.502 14.228
Total Operating Expense 35.72 25.862 17.292 19.204 27.667
Selling/General/Admin. Expenses, Total 16.134 11.931 8.565 9.606 10.554
Research & Development 6.042 4.782 2.933 2.69 4.261
Unusual Expense (Income) 0.149 0.572 0 1.557 3.681
Operating Income -10.831 -8.483 -5.946 -7.351 -5.302
Interest Income (Expense), Net Non-Operating -0.749 -0.236 -0.051 -0.309 -0.384
Other, Net 0.272 1.911 -0.062 -0.216 -0.179
Net Income Before Taxes -11.308 -6.808 -6.059 -7.876 -5.865
Net Income After Taxes -11.379 -6.917 -4.799 -6.244 -5.865
Net Income Before Extra. Items -11.379 -6.917 -4.799 -6.244 -5.865
Net Income -11.379 -6.542 0.296 -2.863 -5.865
Total Adjustments to Net Income 0 4.894
Income Available to Common Excl. Extra. Items -11.379 -6.917 -4.799 -1.35 -5.865
Income Available to Common Incl. Extra. Items -11.379 -6.542 0.296 2.031 -5.865
Diluted Net Income -11.379 -6.542 0.296 2.031 -5.865
Diluted Weighted Average Shares 49.3249 42.8152 30.1524 22.7397 19.541
Diluted EPS Excluding Extraordinary Items -0.2307 -0.16155 -0.15916 -0.05937 -0.30014
Diluted Normalized EPS -0.22873 -0.15287 -0.15916 -0.01486 -0.11212
Other Operating Expenses, Total 0 0.105 0 1.034
Total Extraordinary Items 0 0.375 5.095 3.381 0
Jul 2023 Apr 2023 Jan 2023 Oct 2022 Jul 2022
Total revenue 5.77 5.332 6.745 6.217 5.992
Revenue 5.77 5.332 6.745 6.217 5.992
Cost of Revenue, Total 2.947 2.786 8.404 3.57 3.204
Gross Profit 2.823 2.546 -1.659 2.647 2.788
Total Operating Expense 8.368 8.328 8.581 9.379 8.648
Selling/General/Admin. Expenses, Total 4.107 3.806 3.646 4.053 3.934
Research & Development 1.305 1.701 1.515 1.754 1.461
Unusual Expense (Income) 0.009 0.035 0.008 0.002 0.049
Operating Income -2.598 -2.996 -1.836 -3.162 -2.656
Interest Income (Expense), Net Non-Operating -0.267 -0.248 -0.23 -0.198 -0.189
Other, Net 0.358 0.396 -0.067 0.231 -0.425
Net Income Before Taxes -2.507 -2.848 -2.133 -3.129 -3.27
Net Income After Taxes -2.515 -2.901 -2.182 -3.138 -3.272
Net Income Before Extra. Items -2.515 -2.901 -2.182 -3.138 -3.272
Total Extraordinary Items 0 0 0
Net Income -2.515 -2.901 -2.182 -3.138 -3.272
Income Available to Common Excl. Extra. Items -2.515 -2.901 -2.182 -3.138 -3.272
Income Available to Common Incl. Extra. Items -2.515 -2.901 -2.182 -3.138 -3.272
Diluted Net Income -2.515 -2.901 -2.182 -3.138 -3.272
Diluted Weighted Average Shares 56.3577 55.9709 55.3097 47.73 47.2313
Diluted EPS Excluding Extraordinary Items -0.04463 -0.05183 -0.03945 -0.06574 -0.06928
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.04452 -0.05142 -0.03936 -0.06572 -0.0686
Other Operating Expenses, Total -4.992
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 15.987 15.119 7.315 6.554 7.807
Cash and Short Term Investments 6.598 9.885 2.409 1.649 2.376
Cash & Equivalents 6.598 9.885 2.409 1.649 2.376
Total Receivables, Net 8.679 4.666 3.103 2.819 4.196
Accounts Receivable - Trade, Net 7.719 3.823 2.929 2.016 2.933
Prepaid Expenses 0.71 0.568 0.416 0.501 1.235
Other Current Assets, Total 0 1.387 1.585
Total Assets 61.521 61.815 25.977 31.698 31.74
Property/Plant/Equipment, Total - Net 0.111 0.341 0.495 0.098 0.237
Property/Plant/Equipment, Total - Gross 0.325 0.315 0.556
Accumulated Depreciation, Total -0.246 -0.192 -0.452 -1.516
Goodwill, Net 23.089 23.089 10.712 10.712 15.537
Intangibles, Net 20.639 22.318 6.569 6.897 7.367
Note Receivable - Long Term 0.407
Other Long Term Assets, Total 1.695 0.948 0.886 7.437 0.385
Total Current Liabilities 16.775 13.501 7.369 15.638 12.123
Accounts Payable 0.626 0.778 0.272 0.756 1.28
Accrued Expenses 3.3 2.007 1.106 1.395 1.814
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.75 0.25 1.534 3.872 0.597
Other Current Liabilities, Total 12.099 10.466 4.457 9.615 8.432
Total Liabilities 26.01 27.771 8.488 15.693 16.852
Total Long Term Debt 8.964 9.654 0.767 0 3.351
Long Term Debt 8.964 9.654 0.767 0 3.351
Capital Lease Obligations
Other Liabilities, Total 0.271 4.616 0.352 0.055 1.378
Total Equity 35.511 34.044 17.489 16.005 14.888
Preferred Stock - Non Redeemable, Net 8.686
Common Stock 0.576 0.478 0.316 0.305 0.208
Additional Paid-In Capital 131.973 119.225 96.29 95.113 82.544
Retained Earnings (Accumulated Deficit) -97.038 -85.659 -79.117 -79.413 -76.55
Total Liabilities & Shareholders’ Equity 61.521 61.815 25.977 31.698 31.74
Total Common Shares Outstanding 57.5672 47.841 31.598 30.5306 20.7677
Total Preferred Shares Outstanding 2.89546
Jul 2023 Apr 2023 Jan 2023 Oct 2022 Jul 2022
Total Current Assets 8.712 11.519 15.987 16.798 11.179
Cash and Short Term Investments 4.087 5.987 6.598 11.699 5.918
Cash & Equivalents 4.087 5.987 6.598 11.699 5.918
Total Receivables, Net 3.73 4.815 8.679 4.153 4.316
Accounts Receivable - Trade, Net 2.79 4.28 7.719 3.322 3.545
Prepaid Expenses 0.895 0.717 0.71 0.946 0.945
Other Current Assets, Total
Total Assets 53.315 56.486 61.521 62.217 56.962
Property/Plant/Equipment, Total - Net 0.106 0.099 0.111 0.173 0.233
Property/Plant/Equipment, Total - Gross 0.372 0.354 0.325
Accumulated Depreciation, Total -0.266 -0.255 -0.246
Goodwill, Net 23.089 23.089 23.089 23.089 23.089
Intangibles, Net 19.998 20.181 20.639 20.941 21.286
Other Long Term Assets, Total 1.41 1.598 1.695 1.216 1.175
Total Current Liabilities 13.335 14.435 16.775 18.582 14.666
Accounts Payable 0.657 0.299 0.626 0.405 0.669
Accrued Expenses 1.939 2.505 3.3 3.376 2.574
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 1 0.875 0.75 0.625 0.5
Other Current Liabilities, Total 9.739 10.756 12.099 14.176 10.923
Total Liabilities 22.211 23.424 26.01 28.053 28.455
Total Long Term Debt 8.517 8.742 8.964 9.214 9.444
Long Term Debt 8.517 8.742 8.964 9.214 9.444
Other Liabilities, Total 0.359 0.247 0.271 0.257 4.345
Total Equity 31.104 33.062 35.511 34.164 28.507
Common Stock 0.589 0.586 0.576 0.551 0.488
Additional Paid-In Capital 132.933 132.379 131.973 128.469 119.737
Retained Earnings (Accumulated Deficit) -102.418 -99.903 -97.038 -94.856 -91.718
Total Liabilities & Shareholders’ Equity 53.315 56.486 61.521 62.217 56.962
Total Common Shares Outstanding 58.8951 58.6364 57.5672 55.1303 48.8012
Other Equity, Total
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Net income/Starting Line -11.379 -6.542 -4.799 -6.244 -5.865
Cash From Operating Activities -7.143 -3.504 -5.757 -0.008 1.397
Cash From Operating Activities 4.313 0.068 0.064 0.043 0.45
Amortization 3.129 2.153 2.048 2.097
Deferred Taxes
Non-Cash Items 1.798 -1.403 -0.397 7.128 5.905
Cash Taxes Paid 0.023 0.021 0 0.009 0.011
Cash Interest Paid 0.651 0.153 0.017 0.337 0.417
Changes in Working Capital -1.875 1.244 -2.778 -2.983 -1.19
Cash From Investing Activities -1.935 -13.169 9.46 -3.41 -3.003
Capital Expenditures -1.935 -1.499 -1.828 -2.852 -3.024
Other Investing Cash Flow Items, Total 0 -11.67 11.288 -0.558 0.021
Cash From Financing Activities 5.791 24.149 -2.943 2.691 -0.638
Financing Cash Flow Items -2.275 -1.951 -1.244 -1.151 -0.085
Issuance (Retirement) of Stock, Net 8.316 16.1 3.872 0.044
Issuance (Retirement) of Debt, Net -0.25 10 -1.699 -0.03 -0.597
Net Change in Cash -3.287 7.476 0.76 -0.727 -2.244
Apr 2023 Jan 2023 Oct 2022 Jul 2022 Apr 2022
Net income/Starting Line -2.901 -11.379 -9.197 -6.059 -2.787
Cash From Operating Activities 0.126 -7.143 -4.721 -2.951 -1.27
Cash From Operating Activities 1.059 4.313 0.04 0.027 0.014
Amortization 2.812 1.903 0.957
Non-Cash Items 0.247 1.798 1.465 0.922 -0.029
Cash Taxes Paid -0.009
Changes in Working Capital 1.721 -1.875 0.159 0.256 0.575
Cash From Investing Activities -0.433 -1.935 -1.445 -0.881 -0.519
Capital Expenditures -0.433 -1.935 -1.445 -0.881 -0.519
Other Investing Cash Flow Items, Total 0 0 0
Cash From Financing Activities -0.304 5.791 7.98 -0.135 -0.141
Financing Cash Flow Items -0.179 -2.275 -0.211 -0.135 -0.141
Issuance (Retirement) of Stock, Net 8.316 8.316 0 0
Issuance (Retirement) of Debt, Net -0.125 -0.25 -0.125
Net Change in Cash -0.611 -3.287 1.814 -3.967 -1.93

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Streamline Company profile

About Streamline Health Solutions Inc.

Streamline Health Solutions, Inc. is a provider of health information technology solutions and associated services. The Company offers computer software-based solutions and auditing services, which capture, aggregate, and translate structured and unstructured data to deliver organized, easily accessible predictive insights to its customers. It consists of solutions and services to assist its customers in revenue cycle management, including Coding and Clinical Documentation Improvement (CDI), Financial Management and eValuator, flagship cloud-based solution, which delivers automated coding analysis prior to billing. The Company’s software solutions are delivered to customers either by access to the Company’s data center systems through a secure connection in a software as a service (SaaS) delivery method or by a fixed-term or perpetual license. The software is installed locally in the customer’s data center. The Company operates throughout the United States and Canada.

Financial summary

BRIEF: For the nine months ended 31 October 2021, Streamline Health Solutions Inc. revenues increased 35% to $11.3M. Net loss before extraordinary items increased from $3.2M to $6.9M. Revenues reflect Software as a service increase from $2.5M to $5.3M, Professional services increase of 95% to $1.1M, Software licenses increase of 22% to $285K. Higher net loss reflects General and administrative expenses increase of 23% to $5.7M (expense).

Equity composition

Common Stock $.01 Par, 04/11, 25M auth., 9,866,517 issd. Insiders own 40.01%. IPO: 4/96, 2,912,500 shares @ $13.00 by Jefferies & Company, Inc. 07/06, Name changed from LanVision Systems, Inc.

Industry: Healthcare Facilities & Services (NEC)

2400 Old Milton Parkway
Box 1353
ALPHARETTA
GEORGIA 30009
US

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

XRP/USD

0.54 Price
+1.070% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,360.80 Price
-1.290% 1D Chg, %
Long position overnight fee -0.0194%
Short position overnight fee 0.0111%
Overnight fee time 21:00 (UTC)
Spread 0.39

ETH/USD

3,216.93 Price
+2.020% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

65,956.30 Price
+1.940% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading